Document Type : Original Article

Authors

Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran

Abstract

Among the 26 human claudin proteins, the food-poisoning bacterium Clostridium perfringens produces an enterotoxin (~ 35.00 kDa) that specifically targets human claudin 4, causing diarrhea by fluid accumulation in the intestinal cavity. The Clostridium perfringens enterotoxin (CPE) C-terminal domain (cCPE ~ 15.00 kDa) tightly binds to claudin 4 and disrupts the tight junction barriers in the intestines. In this study, we aimed to determine the contribution and type of amino acid interactions involved in association between claudin 4 and the C-terminal CPE. First, the three-dimensional format of claudin 4 was downloaded from RCSB. Then, during 60.00 nanoseconds (nsec), molecular dynamics simulation was conducted using the GROMACS package on CPE of crystallographic structure. The results indicated that the simulations performed well during the simulation times and there were no noticeable problems or artifacts. We found that Coulombic (glycine 317, proline 311 and serine 313) and Lennard-Jones (tyrosine 310, leucine 315, serine 313 and glycine 317) interactions played a significant role in complex stability. This information localized the C-terminal of CPE as a linear sequence sufficient for recognition and binding to the eukaryotic CPE receptor. A detailed description of the dissociation process brings valuable insight into the interaction of the claudin 4-cCPE290-319 complexes, which could help in the future to design more potent drugs.

Keywords

  1. Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev MolCell Biol 2001; 2(4): 285-293.
  2. Krause G, Winkler L, Mueller SL, et al. Structure and function of claudins. Biochim Biophys Acta 2008; 1778(3): 631-645.
  3. Katahira J, Sugiyama H, Inoue N, et al. Clostridium perfringens enterotoxin utilizes two structurally related membrane proteins as functional receptors in vivo. J Biol Chem 1997; 272(42): 26652-26658.
  4. Sasaki H, Matsui C, Furuse K, et al. Dynamic behavior of paired claudin strands within apposing plasma membranes. Proc Natl Acad Sci U S A 2003; 100(7): 3971-3976.
  5. Lu KH, Patterson AP, Wang L, et al. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clin Cancer Res 2004; 10(10): 3291-3300.
  6. Nichols LS, Ashfaq R, Iacobuzio-Donahue CA. Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target. Am J Clin Pathol 2004; 121(2): 226-230.
  7. Morin PJ. Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res 2005; 65(21): 9603-9606.
  8. Santin AD, Zhan F, Cane’ S, et al. Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy. Br J Cancer 2005; 92(8): 1561-1573.
  9. Cheng TC, Manorek G, Samimi G, et al. Identification of genes whose expression is associated with cisplatin resistance in human ovarian carcinoma cells. Cancer Chemother Pharmacol 2006; 58(3): 384-395.
  10. Kominsky SL, Tyler B, Sosnowski J, et al. Clostridium perfringens enterotoxin as a novel-targeted therapeutic for brain metastasis. Cancer Res 2007; 67(17): 7977-7982.
  11. de Souza WF, Fortunato-Miranda N, Robbs BK, et al. Claudin-3 overexpression increases the malignant potential of colorectal cancer cells: roles of ERK1/2 and PI3K-Akt as modulators of EGFR signaling. PLoS One 2013; 8(9): e74994. doi: 10.1371/pone.0074994.
  12. Kolokytha P, Yiannou P, Keramopoulos D, et al. Claudin-3 and claudin-4: distinct prognostic significance in triple-negative and luminal breast cancer. Appl Immunohistochem Mol Morphol 2014; 22(2): 125-131.
  13. Ling J, Liao H, Clark R, et al. Structural constraints for the binding of short peptides to claudin-4 revealed by surface plasmon resonance. J Biol Chem 2008; 283(45): 30585-30595.
  14. McClane BA. The complex interactions between Clostridium perfringens enterotoxin and epithelial tight junctions. Toxicon 2001; 39(11): 1781-1791.
  15. Smedley JG 3rd, McClane BA. Fine mapping of the N-terminal cytotoxicity region of Clostridium perfringens enterotoxin by site-directed mutagenesis. Infect Immun 2004; 72(12): 6914-6923.
  16. Fernández Miyakawa ME, Pistone Creydt V, Uzal FA, et al. Clostridium perfringens enterotoxin damages the human intestine in vitro. Infect Immun 2005; 73(12): 8407-8410.
  17. Singh U, Van Itallie CM, Mitic LL, et al. Caco-2 cells treated with Clostridium perfringens enterotoxin form multiple large complex species, one of which contains the tight junction protein occludin. J Biol Chem 2000; 275(24): 18407-18417.
  18. Singh AK, Jiang Y, Gupta S. Effects of bacterial toxins on endothelial tight junction in vitro: a mechanism-based investigation. Toxicol Mech Methods 2007; 17(6): 331-347.
  19. Smedley JG 3rd, Uzal FA, McClane BA. Identification of a prepore large-complex stage in the mechanism of action of Clostridium perfringens Infect Immun 2007; 75(5): 2381-2390.
  20. Hanna P, Mietzner TA, Schoolnik GK, et al. Localization of the receptor-binding region of Clostridium perfringens enterotoxin utilizing cloned toxin fragments and synthetic peptides. The 30 C-terminal amino acids define a functional binding region. J Biol Chem 1991; 266(17): 11037-11043.
  21. Sugii S. Analysis of multiple antigenic determinants of Clostridium perfringens enterotoxin as revealed by use of different synthetic peptides. J Vet Med Sci 1994; 56(6): 1047-1050.
  22. Kokai-Kun JF, McClane BA. Determination of functional regions of Clostridium perfringens enterotoxin through deletion analysis. Clin Infect Dis 1997: Suppl 2: S165-S167.
  23. Piseri P, Barborini E, Marino M, et al. Hydrogen uptake in cluster-assembled carbon thin films: experiment and computer simulation. J Phys Chem B 2004; 108(17): 5157-5160.
  24. Daggett V. Protein folding− simulation. Chem Rev 2006; 106(5): 1898-1916.
  25. Adcock SA, McCammon JA. Molecular dynamics:  survey of methods for simulating the activity of proteins. Chem Rev 2006; 106 (5): 1589-1615.
  26. van Gunsteren WF, Bakowies D, Baron R, et al. Biomolecular modeling: goals, problems, perspectives. Angew Chem Int Ed Engl 2006; 45(25): 4064-4092.
  27. van Gunsteren WF, Mark AE. On the interpretation of biochemical data by molecular dynamics computer simulation. Eur J Biochem 1992; 204(3): 947-961.
  28. van Gunsteren WF, Dolenc J, Mark AE. Molecular simulation as an aid to experimentalists. Curr Opin Struct Biol 2008; 18(2): 149-153.
  29. Shinoda T, Shinya N, Ito K, et al. Structural basis for disruption of claudin assembly in tight junctions by an enterotoxin. Sci Rep 2016; 6: 33632. doi: 10.1038/ srep33632.
  30. Hess B, Kutzner C, van der Spoel D, et al. GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput 2008; 4(3): 435-447.
  31. Berendsen HJC, van Postma JPM, van Gunsteren WF, et al. Molecular-dynamics with coupling to an external bath. J Chem Phys 1984; 81(8): 3684-3690.
  32. Cheatham TE, Miller JL, Fox T, et al. Molecular dynamics simulations on solvated biomolecular systems: the particle mesh Ewald method leads to stable trajectories of DNA, RNA, and proteins. J Am Chem Soc 1995; 117(14): 4193-4194.
  33. Sanner MF, Olson AJ, Spehner JC. Reduced surface: an efficient way to compute molecular surfaces. Biopolymers 1996; 38(3): 305-320.
  34. Hospital A, Goñi JR, Orozco M, et al. Molecular dynamics simulations: advances and applications. Adv Appl Bioinform Chem 2015; 8: 37-47.
  35. Kufareva I, Abagyan R. Methods of protein structure comparison. Methods Mol Biol 2012; 857: 231-257.
  36. Takahashi A, Komiya E, Kakutani H, et al. Domain mapping of a claudin-4 modulator, the C-terminal region of C-terminal fragment of Clostridium perfringens enterotoxin, by site-directed mutagenesis. Biochem Pharmacol 2008; 75(8): 1639-1648.
  37. Cocco E, Casagrande F, Bellone S, et al. Clostridium perfringens enterotoxin carboxy-terminal fragment is a novel tumor-homing peptide for human ovarian cancer. BMC Cancer. 2010; 10: 349. doi: 10.1186/ 1471-2407-10-349.
  38. Veshnyakova A, Protze J, Rossa J, et al. On the interaction of Clostridium perfringens enterotoxin with claudins. Toxins (Basel) 2010; 2(6): 1336-1356.